Nuwacell Biotechnologies Co., Ltd.
Nuwacell Biotechnologies Co., Ltd.
Explore linked clinical trials.7 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of [89Zr]-Oxine-NCR100 Injection for the Cellular Distribution | KOA | Not yet recruiting | Phase 1 | 2025-08-24 | NCT07139431 | |
| A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR201 in the Treatment of Subjects With Parkinson's Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Phase 1 | 2025-08-01 | NCT06978920 | |
| A Trial to Evaluate the Safety and Efficacy of NCR102 in Subjects With aGVHD | Acute Graft-versus-Host Disease | Not yet recruiting | Phase 1 / Phase 2 | 2025-04-23 | NCT06941350 | |
| A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR101 in the Treatment of Subjects With Interstitial Lung Disease | interstitial lung disease, lung disorder, respiratory system disorder | Not yet recruiting | Phase 1 / Phase 2 | 2025-02-13 | NCT06825169 | |
| A Study of NCR100 Injection for the Treatment of Knee Osteoarthritis（ KOA） | arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder | Not yet recruiting | Phase 1 / Phase 2 | 2024-12-18 | NCT06741098 | |
| A Trial to Evaluate the Safety and Efficacy of NCR300 in Preventing Recurrence of Acute Myeloid Leukemia（AML) After Transplantation | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Not yet recruiting | Phase 1 | 2024-06-04 | NCT06441084 | |
| A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor | Solid Tumor | Not yet recruiting | Not applicable | 2024-02-07 | NCT06245018 |